Add Company
Join Now

LifeCell An Acelity Company Revenue and Competitors

License our Company Data API

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • LifeCell An Acelity Company's estimated annual revenue is currently $87.7M per year.(i)
  • LifeCell An Acelity Company's estimated revenue per employee is $155,000

Employee Data

  • LifeCell An Acelity Company has 566 Employees.(i)
  • LifeCell An Acelity Company grew their employee count by 3% last year.

LifeCell An Acelity Company's People

NameTitleEmail/Phone
1
VP FinanceReveal Email/Phone
2
VP, Head Global Tax (Acelity)/Senior Tax Counsel—Planning (3M)Reveal Email/Phone
3
Executive Assistant to the EVP, General CounselReveal Email/Phone
4
VP, Franchise Leader, Post AcuteReveal Email/Phone
5
VP - Corporate ControllerReveal Email/Phone
6
Regional VP, General Manager ANZReveal Email/Phone
7
Director, Global Travel & Meetings ManagementReveal Email/Phone
8
Director, Corporate AccountsReveal Email/Phone
9
Director, AWT Operations IntegrationReveal Email/Phone
10
Director Business TransformationReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$1.7M11-8%N/AN/A
#2
$14.9M96-6%N/AN/A
#3
$15.2M983%$1.8MN/A
#4
$1.6M100%N/AN/A
#5
$3.4M220%N/AN/A
#6
$2.8M1850%N/AN/A
#7
$7.4M48-2%N/AN/A
#8
$0.8M50%N/AN/A
#9
$1.6M100%N/AN/A
#10
$16.3M10562%N/AN/A
Add Company

What Is LifeCell An Acelity Company?

LifeCell is now an Acelity company! Acelity is a global market leader in advanced wound therapeutics and regenerative medicine, offering innovative solutions from the hospital to home that improve the lives of patients in more than 80 countries. Our mission is to change the practice of medicine with solutions that speed healing, create economic value and improve patients’ lives. We are the undisputed leader in negative pressure wound therapy, the number one provider of regenerative tissue products used for breast reconstruction and hernia repair, and the market leader in collagen dressings. Acelity is headquartered in San Antonio, Texas, with more than 5,800 employees around the globe. LifeCell is focused on the development and commercialization of regenerative and reconstructive acellular tissue matrices for use in general and reconstructive surgical procedures to repair soft tissue defects, as well as autologous fat grafting solutions. The LifeCell portfolio began with ALLODERM™ Regenerative Tissue Matrix, which launched in 1994, and expanded with the launch of STRATTICE™ Reconstructive Tissue Matrix in 2008, the same year that Kinetic Concepts, Inc. (KCI) acquired LifeCell. In 2012, LifeCell further expanded its portfolio with the launch of ALLODERM™ Ready to Use. In June 2013, LifeCell introduced the REVOLVE™ System to offer fast and efficient fat transfer processing for use in a range of aesthetic and reconstructive procedures. In 2014, KCI's parent company announced that KCI, LifeCell and Systagenix would operate under one global medical technology brand known as Acelity.

keywords:N/A

N/A

Total Funding

566

Number of Employees

$87.7M

Revenue (est)

3%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$114M5674%N/A
#2
$35M580N/AN/A
#3
$132.8M59010%N/A
#4
$206.9M613N/AN/A
#5
$112M6183%N/A